Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

AMG-9810

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
AMG-9810
Identifiers
  • (E)-3-(4-tert-butylphenyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)prop-2-enamide
CAS Number
PubChemCID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.164.996Edit this at Wikidata
Chemical and physical data
FormulaC21H23NO3
Molar mass337.419 g·mol−1
3D model (JSmol)
  • CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3
  • InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+
  • Key:GZTFUVZVLYUPRG-IZZDOVSWSA-N

AMG-9810 is a drug which acts as a potent and selectiveantagonist for theTRPV1 receptor.[1] It hasanalgesic andantiinflammatory effects and is used in scientific research, but has not been developed for medical use. It has high antagonist potency and goodbioavailability andpharmacokinetics, and so has been used to study the role of TRPV1 in areas other than pain perception, such as its roles in the brain.[2][3][4][5][6]

See also

[edit]

References

[edit]
  1. ^Doherty EM, Fotsch C, Bo Y, Chakrabarti PP, Chen N, Gavva N, et al. (January 2005). "Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides".Journal of Medicinal Chemistry.48 (1):71–90.doi:10.1021/jm049485i.PMID 15634002.
  2. ^Okun A, DeFelice M, Eyde N, Ren J, Mercado R, King T, Porreca F (January 2011)."Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents".Molecular Pain.7:1744-8069 –7-4.doi:10.1186/1744-8069-7-4.PMC 3025866.PMID 21219650.
  3. ^Shirazi M, Izadi M, Amin M, Rezvani ME, Roohbakhsh A, Shamsizadeh A (August 2014). "Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats".Neurological Sciences.35 (8):1235–41.doi:10.1007/s10072-014-1689-5.PMID 24577898.S2CID 24122557.
  4. ^Amiresmaili S, Shamsizadeh A, Allahtavakoli M, Pourshanazari AA, Roohbakhsh A (February 2014). "The effect of intra-ventral hippocampus administration of TRPV1 agonist and antagonist on spatial learning and memory in male rats".Pharmacological Reports.66 (1):10–4.doi:10.1016/j.pharep.2013.06.002.PMID 24905300.S2CID 15631269.
  5. ^Walters ET (August 2014). "Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense".Experimental Neurology.258:48–61.doi:10.1016/j.expneurol.2014.02.001.PMID 25017887.S2CID 39671969.
  6. ^Bannazadeh M, Fatehi F, Fatemi I, Roohbakhsh A, Allahtavakoli M, Nasiri M, et al. (May 2017). "The role of transient receptor potential vanilloid type 1 in unimodal and multimodal object recognition task in rats".Pharmacological Reports.69 (3):526–531.doi:10.1016/j.pharep.2017.01.025.PMID 31994094.S2CID 210949267.
TRPA
Activators
Blockers
TRPC
Activators
Blockers
TRPM
Activators
Blockers
TRPML
Activators
Blockers
TRPP
Activators
Blockers
TRPV
Activators
Blockers


Stub icon

Thisanalgesic-related article is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=AMG-9810&oldid=1296842575"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp